Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2

Molecular Pharmacology

Volumn 68, Issue 1, 2005, Pages 251-259

  Fujino, Hiromichi ^a   Salvi, Sambhitab ^a   Regan, John W ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; WORTMANNIN;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANDROSTADIENES; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DINOPROSTONE; HUMANS; PHOSPHORYLATION; RECEPTORS, PROSTAGLANDIN E;

EID: 22344439814     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.011833     Document Type: Article

References (18)

1. 4 receptors. J Biol Chem 278:49954-49964.
2. 4 receptor sequestration. Mol Pharmacol 58:1279-1286.
3. Fujino H and Regan JW (2003) Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol Sci 24:335-340.
4. 2. J Biol Chem 277:2614-2619.
5. 2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem 278:12151-12156.
6. Hata AN and Breyer RM (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103:147-166.
7. 2 subtype. J Biol Chem 268:7759-7762.
8. 2-adrenergic stimulation. Circ Res 91:46-53.
9. Johannessen M, Delghandi MP, and Moens U (2004) What turns CREB on? Cell Signal 16:1211-1227.
10. Mayr B and Montminy M (2001) Transcriptional regulation by the phosphorylationdependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
11. 4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol Pharmacol 50:1031-1037.
12. 4 receptor-evoked ERK activation. J Biol Chem 279:29797-29804.
13. 4 prostanoid receptor signaling. Life Sci 74:143-153.
14. 2 subtype. Mol Pharmacol 46:213-220.
15. 2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276:18075-18081.
16. Toh H, Ichikawa A, and Narumiya S (1995) Molecular evolution of receptors for eicosanoids. FEBS Lett 361:17-21.
17. Toker A (2000) Protein kinases as mediators of phosphoinostide 3-kinase signaling. Mol Pharmacol 57:652-658.
18. Vanhaesebroeck B and Waterfield MD (1999) Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239-254.